{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:16:30Z","timestamp":1789175790183,"version":"build-2803163510"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012295","name":"Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>While ulcerative colitis (UC)\u2013associated inflammation primarily occurs in the colon, subclinical terminal ileum inflammation has been previously observed. Given that colonic microbial dysbiosis is common in UC, we profiled the terminal ileum microbiota to determine the extent of gastrointestinal dysbiosis in UC.<\/jats:p>","DOI":"10.1093\/ibd\/izaf160","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:56:34Z","timestamp":1751529394000},"page":"3228-3232","source":"Crossref","is-referenced-by-count":2,"title":["Bacterial Dysbiosis Observed in the Terminal Ileum of Ulcerative Colitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-802X","authenticated-orcid":false,"given":"Jordan S","family":"Mar","sequence":"first","affiliation":[{"name":"Genentech Research & Early Development, Genentech Inc. , 1 DNA Way , South San Francisco, CA, 94080,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Genentech Research & Early Development, Genentech Inc. , 1 DNA Way , South San Francisco, CA, 94080,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Scherl","sequence":"additional","affiliation":[{"name":"Genentech Research & Early Development, Genentech Inc. , 1 DNA Way , South San Francisco, CA, 94080,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Wittke","sequence":"additional","affiliation":[{"name":"Genentech Research & Early Development, Genentech Inc. , 1 DNA Way , South San Francisco, CA, 94080,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Doona","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne NE1 4LP,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Lamb","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne NE1 4LP,","place":["United Kingdom"]},{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne NE2 4HH,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Keir","sequence":"additional","affiliation":[{"name":"Genentech Research & Early Development, Genentech Inc. , 1 DNA Way , South San Francisco, CA, 94080,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"2025112116472501200_izaf160-B1","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"2025112116472501200_izaf160-B2","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1097\/MIB.0000000000000911","article-title":"Prospective evaluation of terminal ileitis in a surveillance population of patients with ulcerative colitis","volume":"22","author":"Hamilton","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2025112116472501200_izaf160-B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112116472501200_izaf160-B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40168-023-01486-1","article-title":"IL-22 alters gut microbiota composition and function to increase aryl hydrocarbon receptor activity in mice and humans","volume":"11","author":"Mar","year":"2023","journal-title":"Microbiome."},{"key":"2025112116472501200_izaf160-B5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol."},{"key":"2025112116472501200_izaf160-B6","doi-asserted-by":"crossref","first-page":"D785","DOI":"10.1093\/nar\/gkab776","article-title":"GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy","volume":"50","author":"Parks","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2025112116472501200_izaf160-B7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"2025112116472501200_izaf160-B8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12866-023-03084-5","article-title":"Diagnosis of Crohn\u2019s disease and ulcerative colitis using the microbiome","volume":"23","author":"Kang","year":"2023","journal-title":"BMC Microbiol."},{"key":"2025112116472501200_izaf160-B9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ecco-jcc\/jjv223","article-title":"Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis","volume":"10","author":"Alipour","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2025112116472501200_izaf160-B10","doi-asserted-by":"crossref","first-page":"e0146162","DOI":"10.1371\/journal.pone.0146162","article-title":"Pglyrp-regulated gut microflora Prevotella falsenii, parabacteroides distasonis and Bacteroides eggerthii enhance and Alistipes finegoldii attenuates colitis in mice","volume":"11","author":"Dziarski","year":"2016","journal-title":"PLoS One"},{"key":"2025112116472501200_izaf160-B11","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/ibd\/izae080","article-title":"Anti-inflammatory effects of bacteroidota strains derived from outstanding donors of fecal microbiota transplantation for the treatment of ulcerative colitis","volume":"30","author":"Ishikawa","year":"2024","journal-title":"Inflamm Bowel Dis."},{"key":"2025112116472501200_izaf160-B12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/0-387-30744-3_35","volume-title":"The Prokaryotes. Bacteria: Firmicutes, Cyanobacteria","author":"Cotta","year":"2006"},{"key":"2025112116472501200_izaf160-B13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025112116472501200_izaf160-B14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ecco-jcc\/jjz064","article-title":"Butyrate does not protect against inflammation-induced loss of epithelial barrier function and cytokine production in primary cell monolayers from patients with ulcerative colitis","volume":"13","author":"Vancamelbeke","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2025112116472501200_izaf160-B15","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1136\/gutjnl-2018-316250","article-title":"Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation","volume":"68","author":"Singh","year":"2019","journal-title":"Gut."},{"key":"2025112116472501200_izaf160-B16","doi-asserted-by":"crossref","first-page":"883495","DOI":"10.3389\/fmicb.2022.883495","article-title":"The distinguishing bacterial features from active and remission stages of ulcerative colitis revealed by paired fecal metagenomes","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Microbiol"},{"key":"2025112116472501200_izaf160-B17","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.3748\/wjg.v27.i28.4722","article-title":"Relationship between clini\u00adcal features and intestinal microbiota in Chinese patients with ulcerative colitis","volume":"27","author":"He","year":"2021","journal-title":"World J Gastroenterol."},{"key":"2025112116472501200_izaf160-B18","doi-asserted-by":"crossref","first-page":"e06432","DOI":"10.1016\/j.heliyon.2021.e06432","article-title":"Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia","volume":"7","author":"Gryaznova","year":"2021","journal-title":"Heliyon."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/11\/3228\/64112184\/izaf160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/11\/3228\/64112184\/izaf160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:47:35Z","timestamp":1763761655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/11\/3228\/8239993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":18,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,8,22]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf160","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,8,22]]}}}